Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX – Get Rating) has been assigned a consensus rating of “Buy” from the nine research firms that are currently covering the firm, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12 month target price among brokerages that have covered the stock in the last year is $22.00.
MDRX has been the topic of a number of research reports. StockNews.com downgraded shares of Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a report on Friday, May 13th. Piper Sandler reduced their target price on shares of Allscripts Healthcare Solutions from $22.00 to $19.00 in a report on Friday, May 6th. Deutsche Bank Aktiengesellschaft upgraded shares of Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating and boosted their target price for the stock from $20.00 to $26.00 in a report on Friday, March 4th. SVB Leerink boosted their target price on shares of Allscripts Healthcare Solutions from $22.00 to $24.00 and gave the stock an “outperform” rating in a report on Thursday, March 3rd. Finally, TheStreet downgraded shares of Allscripts Healthcare Solutions from a “b” rating to a “c” rating in a report on Friday, May 6th.
In other Allscripts Healthcare Solutions news, CEO Richard J. Poulton sold 10,000 shares of the business’s stock in a transaction dated Monday, May 16th. The shares were sold at an average price of $17.94, for a total value of $179,400.00. Following the completion of the sale, the chief executive officer now directly owns 761,674 shares of the company’s stock, valued at approximately $13,664,431.56. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Paul Black sold 60,000 shares of the business’s stock in a transaction dated Thursday, March 10th. The shares were sold at an average price of $21.87, for a total transaction of $1,312,200.00. The disclosure for this sale can be found here. Insiders have sold a total of 171,537 shares of company stock worth $3,334,450 over the last quarter. 2.29% of the stock is currently owned by insiders.
A number of institutional investors have recently added to or reduced their stakes in the business. C M Bidwell & Associates Ltd. purchased a new stake in shares of Allscripts Healthcare Solutions in the 1st quarter worth approximately $44,000. Maverick Capital Ltd. purchased a new stake in shares of Allscripts Healthcare Solutions in the 3rd quarter worth approximately $55,000. AdvisorShares Investments LLC purchased a new stake in shares of Allscripts Healthcare Solutions in the 1st quarter worth approximately $186,000. CIBC Asset Management Inc purchased a new stake in shares of Allscripts Healthcare Solutions in the 4th quarter worth approximately $200,000. Finally, Janus Henderson Group PLC purchased a new stake in Allscripts Healthcare Solutions during the third quarter valued at approximately $213,000.
Shares of NASDAQ MDRX opened at $16.73 on Friday. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.38 and a current ratio of 2.38. The company has a market cap of $1.94 billion, a P/E ratio of 14.94, a P/E/G ratio of 1.48 and a beta of 0.98. The firm’s fifty day moving average is $21.01 and its two-hundred day moving average is $19.40. Allscripts Healthcare Solutions has a 52-week low of $13.05 and a 52-week high of $23.25.
Allscripts Healthcare Solutions (NASDAQ:MDRX – Get Rating) last announced its quarterly earnings results on Thursday, May 5th. The software maker reported $0.09 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.04). Allscripts Healthcare Solutions had a net margin of 11.60% and a return on equity of 10.97%. The company had revenue of $142.70 million during the quarter, compared to the consensus estimate of $139.67 million. During the same quarter in the prior year, the firm posted $0.13 earnings per share. The business’s revenue was up 6.7% on a year-over-year basis. As a group, analysts forecast that Allscripts Healthcare Solutions will post 0.69 EPS for the current fiscal year.
About Allscripts Healthcare Solutions (Get Rating)
Allscripts Healthcare Solutions, Inc, together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Receive News & Ratings for Allscripts Healthcare Solutions Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com’s FREE daily email newsletter.